Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) is -25.23% lower on its value in year-to-date trading and has touched a low of $12.51 and a high of $22.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TEVA stock was last observed hovering at around $16.71 in the last trading session, with the day’s loss setting it -0.23%.
Currently trading at $16.48, the stock is 1.30% and -9.28% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.41 million and changing -1.38% at the moment leaves the stock -7.62% off its SMA200. TEVA registered 22.07% gain for a year compared to 6-month loss of -10.48%. The firm has a 50-day simple moving average (SMA 50) of $18.1666 and a 200-day simple moving average (SMA200) of $17.83845.
The stock witnessed a 1.42% gain in the last 1 month and extending the period to 3 months gives it a -1.96%, and is 2.36% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.50% over the week and 4.04% over the month.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has around 36167 employees, a market worth around $18.88B and $16.53B in sales. Fwd P/E is 5.98. Profit margin for the company is -9.91%. Distance from 52-week low is 31.73% and -27.72% from its 52-week high. The company has generated returns on investments over the last 12 months (-7.56%).
with sales reaching $3.98B over the same period.The EPS is expected to grow by 2.39% this year, but quarterly earnings will post 3.61% year-over-year. Quarterly sales are estimated to grow 4.30% in year-over-year returns.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Top Institutional Holders
787.0 institutions hold shares in Teva- Pharmaceutical Industries Ltd. ADR (TEVA), with institutional investors hold 60.39% of the company’s shares. The shares outstanding are 1.15B, and float is at 1.15B with Short Float at 2.43%. Institutions hold 60.39% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 42.99 million shares valued at $698.55 million. The investor’s holdings represent 3.8279% of the TEVA Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 41.98 million shares valued at $682.15 million to account for 3.7381 of the shares outstanding. The other top investors are ION ASSET MANAGEMENT LTD. which holds 36.33 million shares representing 3.2065% and valued at over $590.36 million, while CLAL INSURANCE ENTERPRISES HOLDINGS LTD holds 2.8543 of the shares totaling 32.34 million with a market value of $525.67 million.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Activity
The most recent transaction is an insider sale by Daniell Richard, the company’s Exec. VP, European Commercial. SEC filings show that Daniell Richard sold 70,961 shares of the company’s common stock on Mar 05 ’25 at a price of $15.91 per share for a total of $1.13 million. Following the sale, the insider now owns 48384.0 shares.
Teva- Pharmaceutical Industries Ltd. ADR disclosed in a document filed with the SEC on Mar 04 ’25 that Hughes Eric A (See “Remarks”) sold a total of 15,174 shares of the company’s common stock. The trade occurred on Mar 04 ’25 and was made at $15.73 per share for $0.24 million. Following the transaction, the insider now directly holds 8077.0 shares of the TEVA stock.
Still, SEC filings show that on Mar 05 ’25, Hughes Eric A (See “Remarks”) disposed off 8,077 shares at an average price of $15.91 for $0.13 million. The insider now directly holds 0 shares of Teva- Pharmaceutical Industries Ltd. ADR (TEVA).
